Overall rank by patents
#7,453
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Omniscient Neurotechnology Pty Limited
USPTO PatentsView assignee record — 44 granted patents across 10 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA).
44
Total patents granted
10
CPC technology areas
19.4
Avg claims per patent
—
5-year filing velocity
The verdict
Omniscient holds 44 US patents across 10 technology areas — rank #7,453 of 50,000 tracked assignees.
- #7,453
- of 50,000 US assignees by volume
- Top 10%
- by Innovation Score (52.7/100)
- 19.4
- avg claims per patent
Portfolio overview
Omniscient Neurotechnology Pty Limited has been granted 44 US utility patents between 2021 and 2025, placing Omniscient Neurotechnology Pty Limited at rank #7,453 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.4 claims per patent with primary concentration in G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA). As a Foreign Corporation, Omniscient Neurotechnology Pty Limited is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 52.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 44 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Omniscient Neurotechnology Pty Limited's 19.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Omniscient Neurotechnology Pty Limited against peers pursuing similar technology classes.
How does Omniscient compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Omniscient Neurot… ◀ 44
Omniscient Neurotechnology Pty Limited
44 patents
What this shows Omniscient holds 44 patents — placing it at rank #7,453 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
Omniscient's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
53 Top 10% higher than 90% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025
USPTO utility patent grants by year · 2021–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 12 | 27.3% |
| 2022 | 15 | 34.1% |
| 2023 | 11 | 25.0% |
| 2024 | 4 | 9.1% |
| 2025 | 2 | 4.5% |
Which technologies does Omniscient Neurotechnology Pty Limited patent most?
Top 10 of 10 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Frequently Asked Questions
How many patents does Omniscient Neurotechnology Pty Limited hold?
Omniscient Neurotechnology Pty Limited holds 44 US granted patents filed between 2021 and 2025, spanning 10 technology areas.
What is Omniscient Neurotechnology Pty Limited's Innovation Score?
Omniscient Neurotechnology Pty Limited has an Innovation Score of 52.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Omniscient Neurotechnology Pty Limited focus on?
Omniscient Neurotechnology Pty Limited's top technology area is G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA) with 35 patents. The company has filed patents in 10 CPC subclasses total.
Is Omniscient Neurotechnology Pty Limited's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Omniscient Neurotechnology Pty Limited.
What does claim depth mean for Omniscient Neurotechnology Pty Limited's patents?
Omniscient Neurotechnology Pty Limited's patents average 19.4 claims each. This falls within the standard range, providing solid legal coverage.
How is the Omniscient Neurotechnology Pty Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
How to use this portfolio
Omniscient's 44 grants land it in the top 10% by Innovation Score — but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance — Omniscient ranks #7,453 of 50,000. Top 50 holders
- Most of this portfolio concentrates in G16H — see who else leads that technology area. G16H leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Explore the patent dataset
G16H technology
Omniscient Neurotechnology Pty Limited's primary CPC class — all holders and yearly trends
Top 50 patent holders
See where Omniscient Neurotechnology Pty Limited ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Data sources used on this page
- USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
- Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
- USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov
